Fluorescent imaging using indocyanine green during esophagectomy to prevent surgical morbidity: a systematic review and meta-analysis.

Maxime D Slooter, Wietse J Eshuis, Miguel A Cuesta, Suzanne S Gisbertz, Mark I van Berge Henegouwen
Author Information
  1. Maxime D Slooter: Department of Surgery, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  2. Wietse J Eshuis: Department of Surgery, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  3. Miguel A Cuesta: Department of Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
  4. Suzanne S Gisbertz: Department of Surgery, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  5. Mark I van Berge Henegouwen: Department of Surgery, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Abstract

BACKGROUND: Fluorescent imaging using indocyanine green (ICG) is an emerging technique that aids the surgeon with intraoperative decision making during upper gastrointestinal cancer surgery. In this systematic review we aim to provide an overview of current practice of fluorescence imaging using ICG during esophagectomy, and to show how this technology can prevent surgical morbidity, such as anastomotic leakage, graft necrosis and chylothorax.
METHODS: The PRISMA standard for systematic reviews was used. The PubMed and Embase database were searched to identify articles matching our systematic literature search. Two authors screened all included articles for eligibility. Risk of bias was assessed for all included articles.
RESULTS: A total of 25 articles were included in this review: 22 articles on perfusion assessment, and three on the detection of chyle fistula. Five out of 22 articles concerning perfusion assessment evaluated fluorescence signals in quantitative values. In 20 articles the pooled incidence of anastomotic leakage and graft necrosis in the ICG group was 11.10% (95% CI: 8.06-15.09%) and in eight studies the pooled change in management rate was 24.55% (95% CI: 19.16-30.88%). After change in management, the pooled incidence of anastomotic leakage and graft necrosis was 14.08% (95% CI: 6.55-27.70%). A meta-analysis showed that less anastomotic leakages and graft necrosis occur in the ICG group (OR 0.30, 95% CI: 0.14-0.63). Three case-reports (N=3) were identified regarding chyle fistula detection, and ICG lymphography detected the thoracic duct in all cases and the chyle fistula in one case.
CONCLUSIONS: Fluorescence imaging using ICG is a promising and safe technology to reduce surgical morbidity after esophagectomy with continuity restoration. ICG fluorescence angiography showed a reduction in anastomotic leakage and graft necrosis. Future studies are needed to demonstrate the feasibility of ICG lymphography for chyle fistula detection.

Keywords

References

  1. Dis Esophagus. 2004;17(2):141-5 [PMID: 15230727]
  2. Surg Today. 2009;39(5):421-4 [PMID: 19408081]
  3. Esophagus. 2011 Dec;8(4):259-266 [PMID: 22557942]
  4. N Engl J Med. 2012 May 31;366(22):2074-84 [PMID: 22646630]
  5. Surg Today. 2013 Feb;43(2):215-20 [PMID: 22782594]
  6. Acta Chir Belg. 2012 Jul-Aug;112(4):275-80 [PMID: 23008991]
  7. Surg Today. 2013 Feb;43(2):206-10 [PMID: 23108512]
  8. Am J Surg. 2013 Mar;205(3):349-52; discussion 352-3 [PMID: 23414958]
  9. Cancer. 2013 Sep 15;119(18):3411-8 [PMID: 23794086]
  10. World J Surg. 2014 Jan;38(1):138-43 [PMID: 24196170]
  11. BMC Med Imaging. 2014 May 22;14:18 [PMID: 24885891]
  12. Ann Surg. 2015 Jul;262(1):74-8 [PMID: 25029436]
  13. Case Rep Surg. 2014;2014:464017 [PMID: 25105050]
  14. Int J Cancer. 2015 Mar 1;136(5):E359-86 [PMID: 25220842]
  15. Innovations (Phila). 2014 Sep-Oct;9(5):391-3 [PMID: 25238427]
  16. J Surg Res. 2015 Apr;194(2):394-9 [PMID: 25472574]
  17. J Gastrointest Surg. 2015 May;19(5):806-12 [PMID: 25791907]
  18. Surg Oncol. 2015 Sep;24(3):181-6 [PMID: 26116395]
  19. J Am Coll Surg. 2015 Aug;221(2):e37-42 [PMID: 26206660]
  20. Anticancer Res. 2015 Nov;35(11):6201-5 [PMID: 26504051]
  21. Langenbecks Arch Surg. 2016 Sep;401(6):767-75 [PMID: 26968863]
  22. Gland Surg. 2016 Apr;5(2):133-49 [PMID: 27047782]
  23. Eur J Cardiothorac Surg. 2016 Dec;50(6):1019-1024 [PMID: 27068552]
  24. J Am Coll Surg. 2016 May;222(5):e67-9 [PMID: 27113525]
  25. Medicine (Baltimore). 2016 Jul;95(30):e4386 [PMID: 27472732]
  26. J Laparoendosc Adv Surg Tech A. 2017 Dec;27(12):1305-1308 [PMID: 28817358]
  27. Surg Endosc. 2018 Apr;32(4):1749-1754 [PMID: 28916846]
  28. Esophagus. 2017;14(4):351-359 [PMID: 28983231]
  29. Int J Surg. 2017 Dec;48:210-214 [PMID: 29146267]
  30. J Am Coll Surg. 2018 Mar;226(3):241-251 [PMID: 29174858]
  31. Am J Surg. 2018 Sep;216(3):524-527 [PMID: 29203037]
  32. Dis Esophagus. 2018 Dec 1;31(12):null [PMID: 29897432]
  33. Int J Gynaecol Obstet. 2018 Dec;143(3):313-318 [PMID: 30125949]
  34. Int J Cancer. 2019 Apr 15;144(8):1941-1953 [PMID: 30350310]
  35. Surg Endosc. 2019 Feb;33(2):384-394 [PMID: 30386983]
  36. J Surg Res. 2019 Feb;234:303-310 [PMID: 30527489]

Word Cloud

Created with Highcharts 10.0.0ICGarticlesanastomoticgraftnecrosischylefistulaimagingusingsystematicesophagectomyleakage95%CI:greenfluorescencesurgicalincludedperfusiondetectionpooledFluorescentindocyanineuppergastrointestinalsurgeryreviewtechnologypreventmorbidity22assessmentincidencegroupstudieschangemanagementmeta-analysisshowed0lymphographyBACKGROUND:emergingtechniqueaidssurgeonintraoperativedecisionmakingcanceraimprovideoverviewcurrentpracticeshowcanchylothoraxMETHODS:PRISMAstandardreviewsusedPubMedEmbasedatabasesearchedidentifymatchingliteraturesearchTwoauthorsscreenedeligibilityRiskbiasassessedRESULTS:total25review:threeFiveconcerningevaluatedsignalsquantitativevalues201110%806-1509%eightrate2455%1916-3088%1408%655-2770%lessleakagesoccurOR3014-063Threecase-reportsN=3identifiedregardingdetectedthoracicductcasesonecaseCONCLUSIONS:FluorescencepromisingsafereducecontinuityrestorationangiographyreductionFutureneededdemonstratefeasibilitymorbidity:Indocyanine

Similar Articles

Cited By